Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.58 |
| ▸ | RECQL | P46063 | 2/20 | 0.58 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.58 |
| ▸ | KEAP1 | Q14145 | 2/20 | 0.56 |
| ▸ | IL1RN | P18510 | 1/20 | 0.55 |
| ▸ | ERAP1 | Q9NZ08 | 1/20 | 0.55 |
| ▸ | CA1 | P00915 | 2/20 | 0.53 |
| ▸ | CA2 | P00918 | 2/20 | 0.53 |
| ▸ | CA9 | Q16790 | 2/20 | 0.53 |
| ▸ | KMT2A | Q03164 | 4/20 | 0.52 |
| ▸ | MEN1 | O00255 | 3/20 | 0.52 |
| ▸ | PKM | P14618 | 1/20 | 0.52 |
| ▸ | HTR6 | P50406 | 1/20 | 0.51 |
| ▸ | FFAR4 | Q5NUL3 | 1/20 | 0.51 |
| ▸ | MAPT | P10636 | 2/20 | 0.50 |
| ▸ | PIK3CG | P48736 | 1/20 | 0.50 |
| ▸ | G6PD | P11413 | 1/20 | 0.50 |
| ▸ | NFKBIA | P25963 | 1/20 | 0.50 |
| ▸ | AGTR1 | P30556 | 1/20 | 0.50 |
| ▸ | METAP2 | P50579 | 1/20 | 0.50 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30737452 | 1.00 | ALDH1A1 (0.58) | ALDH1A1RECQLSMN1; SMN2KEAP1IL1RN | |
| Hydrochloric Acid SCHEMBL29885455 | 0.98 | ALDH1A1 (0.56) | ALDH1A1RECQLSMN1; SMN2KEAP1IL1RN | |
| SCHEMBL30737499 | 0.85 | ALDH1A1 (0.66) | ALDH1A1KMT2AMEN1SLC40A1GAA | |
| SCHEMBL6561655 | 0.85 | MEN1 (0.66) | KEAP1KMT2AMEN1PKMGLO1 | |
| SCHEMBL398000 | 0.85 | LMNA (0.70) | ALDH1A1SMN1; SMN2KEAP1CA1CA2 | |
| SCHEMBL30737629 | 0.85 | MEN1 (0.66) | KEAP1KMT2AMEN1PKMGLO1 | |
| SCHEMBL4184006 | 0.85 | ALDH1A1 (0.66) | ALDH1A1KMT2AMEN1SLC40A1GAA | |
| SCHEMBL15145878 | 0.85 | MEN1 (0.52) | ALDH1A1SMN1; SMN2CA1CA2CA9 | |
| SCHEMBL2067538 | 0.85 | ALDH1A1 (0.68) | ALDH1A1RECQLSMN1; SMN2KEAP1IL1RN | |
| SCHEMBL5595259 | 0.85 | PGR (0.59) | ALDH1A1SMN1; SMN2KEAP1KMT2AMEN1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 53 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12037309-B2 | Compound, agent and composition for the suppression of cancer growth | VECTOR VITALE IP LLC (US) | 2024-07-16 | — | — | US | disclosed |
| US-12037309-B2 | Compound, agent and composition for the suppression of cancer growth | VECTOR VITALE IP LLC (US) | 2024-07-16 | — | — | US | disclosed |
| US-12036238-B2 | Method of treating parkinson's and other neurodegenerative diseases | VECTOR VITALE IP LLC (US) | 2024-07-16 | — | — | US | disclosed |
| US-12036238-B2 | Method of treating parkinson's and other neurodegenerative diseases | VECTOR VITALE IP LLC (US) | 2024-07-16 | — | — | US | disclosed |
| US-11827588-B2 | Compound, agent and composition for the suppression of cancer growth | VECTOR VITALE IP LLC (US) | 2023-11-28 | — | — | US | disclosed |
| US-11827588-B2 | Compound, agent and composition for the suppression of cancer growth | VECTOR VITALE IP LLC (US) | 2023-11-28 | — | — | US | disclosed |
| US-11779597-B2 | Method of treating Parkinson's and other neurodegenerative diseases | VECTOR VITALE IP LLC (US) | 2023-10-10 | — | — | US | disclosed |
| US-11779597-B2 | Method of treating Parkinson's and other neurodegenerative diseases | VECTOR VITALE IP LLC (US) | 2023-10-10 | — | — | US | disclosed |
| US-20230210894-A1 | RUBIDIUM AND/OR ZINC COMPOUNDS FOR TREATING PARKINSON'S AND OTHER NEURODEGENERATIVE DISEASES | VECTOR VITALE IP LLC (US) | 2023-07-06 | — | — | US | disclosed |
| US-20230210894-A1 | RUBIDIUM AND/OR ZINC COMPOUNDS FOR TREATING PARKINSON'S AND OTHER NEURODEGENERATIVE DISEASES | VECTOR VITALE IP LLC (US) | 2023-07-06 | — | — | US | disclosed |
| US-7294716-B2 | Process for preparing isomerically pure prodrugs of proton pump inhibitors | ALLERGAN, INC. (US) | 2007-11-13 | — | — | US | disclosed |
| EP-1818325-A2 | 3,4-DI-substituted cyclobutene-1,2-diones as CXC-chemokine receptor ligands | SCHERING CORPORATION (US) | 2007-08-15 | — | — | EP | disclosed |
| US-20070142639-A1 | Process for production of amines | TAKASAGO INTERNATIONAL CORPORATION (JP) | 2007-06-21 | — | — | US | disclosed |
| EP-1381590-B1 | 3,4-DI-SUBSTITUTED CYCLOBUTENE-1,2-DIONES AS CXC-CHEMOKINE RECEPTOR LIGANDS | SCHERING CORP (US) | 2007-06-20 | — | — | EP | disclosed |
| US-20070021494-A1 | 3,4-Di-substituted cyclobutene-1,2-diones as CXC-chemokine receptor ligands | SCHERING CORPORATION AND PHARMACOPEIA, INC. | 2007-01-25 | — | — | US | disclosed |
| US-20070021494-A1 | 3,4-Di-substituted cyclobutene-1,2-diones as CXC-chemokine receptor ligands | SCHERING CORPORATION AND PHARMACOPEIA, INC. | 2007-01-25 | — | — | US | disclosed |
| US-6180796-B1 | TUBULIN POLYMERIZATION INHIBITORS | NIPPON KAYAKU KABUSHIKI KAISHA (JP) | 2001-01-30 | — | — | US | disclosed |
| US-5760196-A | PRINTING AND DYEING HYDROPHOBIC FIBERS OF POLYESTERS FOR COLORFASTNESS | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 1998-06-02 | — | — | US | disclosed |
| EP-0727464-A2 | Monoazo compounds and methods for dyeing or printing hydrophobic fiber materials using the same | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 1996-08-21 | — | — | EP | disclosed |
| US-4241079-A | ANTHELMINTICS AND FUNGICIDES | ROHM AND HAAS COMPANY (US) | 1980-12-23 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (7 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20070021494-A1 | 3,4-Di-substituted cyclobutene-1,2-diones as CXC-chemokine receptor ligands | CCR1, ACKR3, CXCR1 | ALDH1A1 1019/4885RECQL 4150/4885SMN1; SMN2 4403/4885 |
| US-20230210894-A1 | RUBIDIUM AND/OR ZINC COMPOUNDS FOR TREATING PARKINSON'S AND OTHER NEURODEGENERATIVE DISEASES | SOD1, SNCA, SLC39A11 | ALDH1A1 751/4885RECQL 1450/4885SMN1; SMN2 124/4885 |
| US-20070142639-A1 | Process for production of amines | SMS, CCNT1, PEAK1 | ALDH1A1 1001/4885RECQL 3395/4885SMN1; SMN2 2249/4885 |
| US-12036238-B2 | Method of treating parkinson's and other neurodegenerative diseases | SOD1, SNCA, PARK7 | ALDH1A1 911/4885RECQL 1237/4885SMN1; SMN2 77/4885 |
| US-12037309-B2 | Compound, agent and composition for the suppression of cancer growth | RPL32, MKI67, RPL41 | ALDH1A1 1061/4885RECQL 1407/4885SMN1; SMN2 3668/4885 |
| US-11779597-B2 | Method of treating Parkinson's and other neurodegenerative diseases | SOD1, SNCA, PARK7 | ALDH1A1 911/4885RECQL 1237/4885SMN1; SMN2 77/4885 |
| US-11827588-B2 | Compound, agent and composition for the suppression of cancer growth | RPL32, MKI67, RPL41 | ALDH1A1 1061/4885RECQL 1407/4885SMN1; SMN2 3668/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.